Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -32.60% | -59.41% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -32.60% | -59.41% | |
| Cost of Revenue | -- | -- | 117.81% | 113.51% | |
| Gross Profit | -- | -- | -63.44% | -98.10% | |
| SG&A Expenses | -- | -- | -15.48% | -21.05% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -300.00% | -- | |
| Total Operating Expenses | -- | -- | -26.61% | -33.25% | |
| Operating Income | -- | -- | 23.88% | 22.93% | |
| Income Before Tax | -- | -- | 49.27% | 43.59% | |
| Income Tax Expenses | -- | -- | 212.50% | -33.33% | |
| Earnings from Continuing Operations | -- | -- | 49.21% | 43.58% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | 41.80% | 47.66% | |
| Net Income | -- | -- | 28.26% | 29.16% | |
| EBIT | -- | -- | 23.88% | 22.93% | |
| EBITDA | -- | -- | 12.57% | 14.14% | |
| EPS Basic | -- | -- | 42.97% | 45.73% | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | 42.97% | 45.73% | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | 32.31% | 21.83% | |
| Average Diluted Shares Outstanding | -- | -- | 32.31% | 21.83% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |